60 Days and Counting: DOJ’s New Fast Track for Benefits Fraud Qui Tams

Key Takeaways

• The Department of Justice (“DOJ”) has directed its attorneys to review benefits-fraud False Claims Act (“FCA”) whistleblower cases on an accelerated 60- to 120-day timeline, meaning faster intervention, dismissal, or escalation decisions for entities participating in Medicaid and other state-administered federal benefits programs.
• The new framework creates a coordinated civil, criminal, and administrative enforcement model, with mandatory referrals to the National Fraud Enforcement Division (“NFED”) and federal agencies, increasing the risk of parallel FCA investigations, payment suspensions, and criminal exposure.
• Healthcare providers, managed care organizations, and other benefits-program participants should prepare for faster subpoenas, Civil Investigative Demands (“CIDs”), and government inquiries.

On May 27, 2026, Assistant Attorney General Brett A. Shumate issued a memorandum to attorneys in the Commercial Litigation Branch’s Fraud Section and to Assistant United States Attorneys handling FCA cases that may materially accelerate DOJ’s review and coordination of benefits-fraud FCA matters. The memo, entitled “Accelerating Review and Enhancing Enforcement in Benefits Fraud Matters,” implements directives from the March 16, 2026, Executive Order “Establishing the Task Force to Eliminate Fraud” and introduces compressed timelines, new investigative protocols, and a whole-of-government enforcement posture that defense counsel and in-house compliance teams should study carefully.

The Shumate Memo is best understood as one piece of a broader enforcement architecture that has taken shape in 2026. On March 16, President Trump signed Executive Order 14395, establishing a multi-agency Task Force to Eliminate Fraud within the Executive Office of the President, chaired by Vice President JD Vance. The Executive Order’s stated premise is that states administering federally funded benefit programs have “embraced loopholes that avoid individual eligibility validation, allow self-certification of eligibility, and expand eligibility far beyond what the Congress intended,” and that fraud in programs providing housing, food, medical care, and cash assistance has reached crisis proportions. The Task Force’s mandate is broad: developing a comprehensive national anti-fraud strategy, enhancing eligibility verification, implementing pre-payment integrity controls, expanding federal-state information-sharing, and maximizing civil enforcement remedies — including through the False Claims Act. Critically, the Executive Order directed DOJ to “take appropriate action to promote meritorious qui tams” and to “ensure prompt review” of such actions, including within the FCA’s 60-day seal period “to the maximum extent practicable.” Meanwhile, on April 7, Acting Attorney General Todd Blanche formally established the NFED, a new division within DOJ charged with centralizing and elevating criminal and civil fraud enforcement under a single leadership structure with nationwide jurisdiction. The Shumate Memo is DOJ’s first comprehensive attempt to translate the Executive Order’s FCA directives into concrete litigation expectations for review, investigation, and interagency coordination in benefits-fraud enforcement actions.

The New 60/120-Day Framework

The most consequential feature of the Shumate Memo is its aggressive compression of the government’s review timeline for qui tam complaints alleging fraud against federally funded, state-administered benefits programs. Under the FCA, every qui tam action is filed under seal and served only on the government, which has a statutory 60-day window to investigate and decide whether to intervene before the defendant is even notified. In practice, courts have routinely granted extensions, and cases have often remained under seal for one to two years or longer while DOJ undertakes an extensive investigation to complete its review. The Shumate Memo upends that status quo. DOJ will now prioritize completing its initial review of new benefits fraud qui tam actions within 60 days “to the maximum extent practicable,” and no later than 120 days.

At the conclusion of that window, DOJ is directed to pursue one of three paths:

1. permit the relator to proceed with the action and assume primary litigation responsibility, subject to the government’s ongoing supervision and control;
2. conclude that the allegations warrant further government investigation; or
3. determine that the qui tam should be dismissed under 31 U.S.C. § 3730(c)(2)(A) because the allegations lack adequate specificity or are legally deficient. Where the government determines that further investigation is warranted, it will proceed on an expedited 120-day investigative period, with any additional requests for extensions requiring approval from increasingly senior leadership within the Civil Division before seeking court approval.

The third option — affirmative dismissal — is particularly noteworthy for defendants. Although the Supreme Court blessed DOJ’s broad dismissal power in its 2023 decision in United States ex rel. Polansky v. Executive Health Resources, the government historically has exercised its dismissal authority under § 3730(c)(2)(A) sparingly, dismissing roughly 15-25 qui tam cases annually against a backdrop of 800 to nearly 1,300 new cases filed each year. The practical significance here is that the Shumate Memo expressly identifies dismissal as one of the principal outcomes of the initial review period. Indeed, DOJ leadership has signaled such a shift. In February, Deputy Assistant Attorney General Brenna Jenny, in remarks at the Federal Bar Association’s Qui Tam Conference, emphasized DOJ’s “increased commitment” to using § 3730(c)(2)(A) to dismiss meritless qui tam suits.

The Shumate Memo’s explicit inclusion of dismissal as one of three possible outcomes at the end of the 60-to-120-day review window may accelerate this trend. By requiring DOJ attorneys to make a definitive call on every benefits fraud qui tam within a compressed timeline, the memo creates pressure for earlier triage decisions about whether a matter should proceed, be investigated further, or be dismissed. For defense counsel, this presents a meaningful opportunity to advocate early and aggressively for dismissal of legally deficient or factually unsupported complaints before they gain traction.

A New Playbook for Government Investigations

The memo does not merely set deadlines; it prescribes a detailed investigative playbook. DOJ attorneys are directed to develop investigative plans that include schedules for prompt issuance of Inspector General subpoenas and Civil Investigative Demands, early witness interviews, and targeted document requests. The memo explicitly encourages enforcement action against defendants who fail to meet response deadlines, instructing attorneys that “absent a justifiable reason for that failure, an action to enforce the subpoena or CID should be filed.” Additionally, the memo contemplates that relator’s counsel may serve as a “valuable resource” to assist with the government’s investigation, reflecting a more explicit willingness to use relator’s counsel as an investigative resource during the seal-period review.

Notably, the memo also provides guidance on when DOJ should allow a relator to take the lead in litigating a benefits fraud matter. Among the considerations are whether the complaint alleges conduct that would constitute an FCA violation, whether the allegations are corroborated by data analytics or the relator’s inside information, whether the scheme is not novel or complex, whether potential damages fall below the settlement authority delegated to the Director of Civil Fraud Section (described in commentary on the memo as $10 million), and whether aggravating factors — such as beneficiary harm or concealment — are present. When electing to let a relator proceed, DOJ attorneys are directed to communicate that the whistleblower and counsel are expected to “shoulder the obligations of the litigation” and to minimize burdens on the government.

A Whole-of-Government Approach

Perhaps the most concerning development for potential defendants is the memo’s embrace of a “whole-of-government” enforcement posture. New benefits fraud qui tam matters will be promptly referred to NFED for evaluation of potential criminal violations. Matters will also be shared with the affected federal agency to evaluate administrative remedies, including payment suspension. This means that a single qui tam complaint could simultaneously trigger civil litigation, a criminal investigation, and administrative proceedings — a multi-front enforcement approach that dramatically increases the stakes and costs for any entity caught in the crosshairs.

The NFED connection deserves particular attention. We discussed in a Bloomberg Law article that the NFED was designed to centralize and elevate fraud enforcement under a single leadership structure with nationwide jurisdiction. The Shumate Memo now creates a systematic referral pipeline from the Civil Division’s benefits fraud docket directly into the NFED’s criminal enforcement apparatus. This integration means that what begins as a civil qui tam complaint alleging overbilling in a state Medicaid program could rapidly escalate into a coordinated criminal investigation with resources drawn from across DOJ. For companies participating in state-administered federal programs, the practical consequence is clear: what has traditionally been a civil FCA matter may result in exposure to criminal liability.

Scope and Ambiguity

One threshold question the memo leaves partially unanswered is its scope. The directive is addressed to “benefits fraud,” defined as fraud on “federally funded benefits programs administered by states.” This appears to encompass programs like Medicaid, the Supplemental Nutrition Assistance Program, Temporary Assistance for Needy Families, and housing assistance programs, but the limitation to state-administered programs is significant because it appears to leave outside the memo’s immediate focus federally administered programs such as traditional Medicare, which is federally administered and has been a leading historical focus of FCA enforcement.  It would also exclude other recent FCA priority areas that do not involve state-administered benefits programs, such as customs or cybersecurity.

Implications for Defense Counsel and In-House Teams

The practical implications of the Shumate Memo are substantial.

First, the compressed timelines will likely result in more qui tam cases proceeding with relators in the lead as DOJ simply may not have the bandwidth to intervene in every meritorious case within 120 days. The memo itself acknowledges that this framework “will increase the number of benefits fraud matters primarily litigated by relators.” While that might initially seem like welcome news for defendants — DOJ-declined cases historically settle for lower amounts — the memo makes clear that DOJ will maintain oversight and control and will continue to evaluate declined cases for potential dismissal or late intervention.

This staffing reality is further compounded by the fact that DOJ attorney staffing levels are currently at historic lows. It will be interesting to see how the compressed timeline of the Shumate Memo plays out in practice given the limited number of attorneys available to pursue these cases. The ambitious 60/120-day framework assumes a level of prosecutorial bandwidth that simply may not exist, potentially creating a bottleneck that forces even more cases into relator-led litigation or dismissal.

Second, the accelerated CID and subpoena timelines mean that companies must be prepared to respond to government demands on short notice, which can be difficult given that many subpoenas request broad categories of documents and email review, which is time consuming and costly. Entities participating in federally funded programs should reassess their document retention policies, internal reporting channels, and ability to mobilize counsel quickly when a CID arrives. The memo’s instruction that enforcement actions should follow missed deadlines “absent a justifiable reason” underscores the need for prompt, organized responses.

Third, the prompt criminal-referral pathway creates a new and serious dimension of risk. In-house counsel at healthcare companies and other benefits program participants should ensure that their compliance programs are robust enough to detect and remediate issues before they become the subject of a qui tam complaint. In-house teams should be mapping their exposure to federal funds, stress-testing their internal reporting and remediation pathways, and planning for the possibility of parallel proceedings that combine FCA theories, program-integrity actions, and criminal charges. The cost of remediation pales in comparison to the cost of defending simultaneous civil, criminal, and administrative proceedings.

Finally, it is worth noting that the constitutional foundation of the qui tam mechanism itself remains in flux. The Eleventh Circuit is currently considering United States ex rel. Zafirov v. Florida Medical Associates, LLC, in which the district court held that the FCA’s qui tam provisions are unconstitutional. If that ruling is upheld, DOJ’s strategy as outlined in the Shumate Memo of relying more on relators to litigate FCA cases would not be practicable. For now, however, the Shumate Memo signals that DOJ intends to use every tool at its disposal to accelerate benefits fraud enforcement, and companies that participate in state-administered federal programs should take notice.